Andres Herane-Vives

Dr. Andres Herane-Vives


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2015 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
RSRebecca Strawbridge
Rebecca Strawbridge
Danilo ArnoneDanilo Arnone
Danilo Arnone
ADA. Danese
A. Danese
APA. Papadopoulos
A. Papadopoulos
AHAndres Herane-Vives
Andres Herane-Vives
ACA.J. Cleare
A.J. Cleare

25 April 2017 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
TWT Wise
T Wise
LML Marwood
L Marwood
APA M Perkins
A M Perkins
AHAndres Herane-Vives
Andres Herane-Vives
RJR Joules
R Joules
Danilo ArnoneDanilo Arnone
Danilo Arnone
Major depression is associated with altered static functional connectivity in various brain networks, particularly the default mode network (DMN). Dynamic functional connectivity is a novel tool with little application in affective disorders to date, and holds the potential to unravel fluctuations in connectivity strength over time in major depression. We assessed stability of connectivity in major depression between the medial prefrontal cortex (mPFC) and posterior cingulate cortex (PCC), key nodes in the DMN that are implicated in ruminative cognitions. Functional connectivity stability between the mPFC and PCC over the course of a resting-state functional magnetic resonance imaging (fMRI) scan was compared between medication-free patients with major depression and healthy controls matched for age, sex and handedness. We tested replicability of the results in an independent sample using multi-echo resting-state fMRI. The primary sample included 20 patients and 19 controls, while the validation sample included 19 patients and 19 controls. Greater connectivity variability was detected in major depression between mPFC and PCC. This was demonstrated in both samples indicating that the results were reliable and were not influenced by the fMRI acquisition approach used. Our results demonstrate that alterations within the DMN in major depression go beyond changes in connectivity strength and extend to reduced connectivity stability within key DMN regions. Findings were robustly replicated across two independent samples. Further research is necessary to better understand the nature of these fluctuations in connectivity and their relationship to the aetiology of major depression.

1 November 2015 in Journal of Psychiatric Research
Verified
Journal Article
Closed access
AHAndres Herane-Vives
Andres Herane-Vives
VAV. De Angel
V. De Angel
APA. Papadopoulos
A. Papadopoulos
RSRebecca Strawbridge
Rebecca Strawbridge
TWT. Wise
T. Wise
ACA.J. Cleare
A.J. Cleare

1 February 2017 in The British Journal of Psychiatry
Verified
Journal Article
Closed access
PDF file
SFSusanne Fischer
Susanne Fischer
RSRebecca Strawbridge
Rebecca Strawbridge
AHAndres Herane-Vives
Andres Herane-Vives
ACAnthony J. Cleare
Anthony J. Cleare
Background: Many patients with depressive disorders demonstrate resistance to psychological therapy. A frequent finding is hypothalamic–pituitary–adrenal (HPA) axis alterations. As cortisol is known to modulate cognitive processes, those patients may be less likely to profit from psychological therapy.Aims: To conduct a systematic review and meta-analysis on cortisol as a predictor of psychological therapy response.Method: The Cochrane Library, EMBASE, MEDLINE and PsycINFO databases were searched. Records were included if they looked at patients with any depressive disorder engaging in psychological therapy, with a pre-treatment cortisol and a post-treatment symptom measure.Results: Eight articles satisfied our selection criteria. The higher the cortisol levels before starting psychological therapy, the more symptoms patients with depression experienced at the end of treatment and/or the smaller their symptom change.Conclusions: Our findings suggest that patients with depression with elevated HPA functioning are less responsive to psychological therapy.

1 August 2014 in Neuropsychiatric Disease and Treatment
Verified
Journal Article
Open access
Danilo ArnoneDanilo Arnone
Danilo Arnone
TWToby Wise
Toby Wise
ACAnthony J Cleare
Anthony J Cleare
Allan YoungAllan Young
Allan Young
AHAndres Herane-Vives
Andres Herane-Vives
A growing number of studies have used neuroimaging to further our understanding of how brain structure and function are altered in major depression. More recently, these techniques have begun to show promise for the diagnosis and treatment of depression, both as aids to conventional methods and as methods in their own right. In this review, we describe recent neuroimaging findings in the field that might aid diagnosis and improve treatment accuracy. Overall, major depression is associated with numerous structural and functional differences in neural systems involved in emotion processing and mood regulation. Furthermore, several studies have shown that the structure and function of these systems is changed by pharmacological and psychological treatments of the condition and that these changes in candidate brain regions might predict clinical response. More recently, “machine learning” methods have used neuroimaging data to categorize individual patients according to their diagnostic status and predict treatment response. Despite being mostly limited to group-level comparisons at present, with the introduction of new methods and more naturalistic studies, neuroimaging has the potential to become part of the clinical armamentarium and may improve diagnostic accuracy and inform treatment choice at the patient level.

1 February 2018 in Psychoneuroendocrinology
Verified
Journal Article
Closed access
AHAndres Herane-Vives
Andres Herane-Vives
SFSusanne Fischer
Susanne Fischer
VAValeria de Angel
Valeria de Angel
TWToby Wise
Toby Wise
ECEric Cheung
Eric Cheung
ACAnthony J. Cleare
Anthony J. Cleare